Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.83% | -39.73% | -36.97% | -28.86% | -35.66% |
| Total Depreciation and Amortization | 76.46% | 61.26% | 29.53% | 14.73% | 4.43% |
| Total Amortization of Deferred Charges | -9.22% | -5.69% | -2.56% | -4.23% | -4.81% |
| Total Other Non-Cash Items | 38.89% | 86.71% | 17.48% | -11.39% | 8.49% |
| Change in Net Operating Assets | -454.68% | -2,427.51% | 38.49% | -38.58% | 80.79% |
| Cash from Operations | -17.55% | -36.72% | -42.78% | -47.10% | -32.75% |
| Capital Expenditure | 4.92% | -48.52% | -31.44% | -45.82% | -87.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.01% | 94.30% | 56.96% | -271.82% | -1,824.94% |
| Cash from Investing | 115.10% | 88.93% | 54.81% | -289.41% | -2,750.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -86.23% | -88.74% | -537.99% | -298.24% | -77.54% |
| Issuance of Common Stock | -21.54% | -19.91% | -28.16% | 43.02% | 603.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -713.69% |
| Cash from Financing | -30.17% | -28.85% | -17.28% | 58.78% | 695.41% |
| Foreign Exchange rate Adjustments | -195.56% | 171.23% | -147.94% | 44.97% | 146.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.97% | -161.36% | -393.68% | -94.08% | 48.42% |